UnitedHealth Raises 2026 Outlook, but Shrinking Membership Tempers the Rally

UnitedHealth Group (UNH) delivered another beat this week, and it's still hard to say whether the turnaround is finished or just getting started. The insurer raised its 2026 profit outlook, yet the stock gave back its early gains on earnings day.

Third-quarter adjusted EPS came in at $4.69 against $4.14 expected, on revenue of $112.69 billion versus $111.40 billion, CNBC reported. Net income was $4.11 billion, up from $2.35 billion a year ago.

Full-year adjusted EPS guidance now sits at "at least" $20.50, up from $19.50 to $20. Analysts had been forecasting $19.86, according to Yahoo Finance.

The quality of the beat matters. The medical care ratio, the share of premiums paid out for care, fell to 88.4% from 89.9% a year earlier. UnitedHealthcare's operating margin rose to 3.3% from 2.1%, and Optum Health's climbed to 3.2% from 0.2%.

One caveat from MarketBeat's analysis: the quarter included $610 million of favorable reserve development, worth roughly 0.7 points on that ratio. Some of the improvement is a one-time cushion.

"You're finding more members are actually getting into a lower-cost care environment, but more importantly, they're getting into the care environment they actually want to be in." — Wayne DeVeydt, CFO, UnitedHealth Group

DeVeydt backed that up with data. Acute hospital admissions among members fell 15% year over year through the third quarter, while home health admissions rose 10%. Patient-driven appointment scheduling is up 27%.

He wasn't claiming victory on costs, though. Medical costs "continue to be elevated versus historical norms," he told CNBC, with the No Surprises Act dispute process alone adding at least a full percentage point to total medical costs.

That's the bull case in a nutshell: tighter pricing, fewer money-losing plans, and care shifting to cheaper settings. Cash flow supports it, too, with operating cash flow of $25.1 billion over nine months versus $18.6 billion a year ago.

The bear case is membership. UnitedHealthcare served 48.3 million people at the end of September, down from 50.1 million a year earlier, and about 390,000 members are in plans slated to be discontinued for 2027. Revenue is up just 0.6% through nine months.

Shares opened about 5% higher Tuesday and touched $399.88 before fading below the 50-day moving average. They've since recovered, closing Thursday at $407.45, up about 3%, but remain well below the July 52-week high.

Management added some fuel, signaling that Wall Street's current 2027 earnings estimates look too low, Reuters reported. That's a bold claim for a company still shrinking.

The turnaround itself came after a rough two years. UnitedHealth was hit by a major cyberattack, missed its own targets, pulled its outlook and reshuffled senior management, according to Yahoo Finance's recap. Three strong quarters in a row is the first real evidence that the fixes are working.

At about 19 times forward earnings and a $9.28 annual dividend (a 2.4% yield), the stock offers value and income. It also draws money from investors looking for an alternative to the AI trade, which has been under pressure this week.

For investors, the question is what you're buying: margin recovery or growth. Margin recovery has momentum for 2027, but the stock probably needs proof that revenue can turn positive before it re-rates much higher.

Policy is the other swing factor. Medicare Advantage rules and Medicaid eligibility changes have already pushed members out of the plans, and the company has said regulatory and cost pressures at Optum could cost roughly $11 billion over three years, so surprises there can move the stock quickly.

Watch the fourth-quarter medical care ratio without the reserve help, the 2027 membership picture, and any detailed 2027 guidance. A ratio that stays near 88% on its own merit would be the strongest confirmation yet.

Bottom line: UnitedHealth has fixed its profits faster than anyone expected. Now it has to show there's a business worth growing on top of them.